Table 1 Clinical characteristics of study participants with ischemic heart disease

From: Diabetes induces the activation of pro-ageing miR-34a in the heart, but has differential effects on cardiomyocytes and cardiac progenitor cells

  Study participant ID Age Sex Diabetes duration (years) Body weight (kg) Body Mass Index HbA1C LVEF (%) E/A ratio
Non-diabetic 79 56 M - 82.5 29.6 44 55 0.95
  85 71 M - 70.5 24.4 - 30 2.6
  86 88 F - 66.5 26.9 45 47 0.58
  78 64 M - 76.9 25.4 43 31 4.3
  83 53 M - 88 30.5 37 35 0.66
  88 60 M - 110 33.2 39 50 N/A
  89 66 M - 94.7 28.4 32 68 1.39
  98 54 F - 118.3 40.4 35 55 1.48
  100 83 M - 68.8 24.7 37 65 0.72
  104 66 M - 101 34.9 44 39 1.44
  106 47 M - 105 36.3 - 56 1.27
  107 71 M - 82 28.5 41 69 1
  108 69 M - 108.9 33.3 44 30 N/A
  110 58 M - 86.6 30.2 38 57 0.86
  113 64 M - 130.2 40.19 41 49 1.62
  97 72 F - 80.4 29.9 35 59 3.15
  127 65 M - 84 25.925 37 62 0.63
  139 55 F - 57.8 22.08 35 59 1.62
Diabetic 84 73 M 8 72.6 25.3 58 73 1.02
  122 77 F 13 78.7 29.58 43 47 0.48
  80 57 M 2 98.9 33.8 62 31 3.7
  82 69 M 5 105.7 34.5 55 30 1.49
  103 62 M 11 102.4 34.7 74 63 0.98
  131 66 M 20 83 26.26 57 27 0.48
  134 68 M 2 93.8 32.15 51 56 0.7
  92 62 M 4 114.5 36.5 53 57 N/A
  105 77 M 17 76.11 23.8 86 71 N/A
  123 83 M 8 63 23.71 49 41 0.62
  72 70 M 15 77.2 24.4 43 28 1.23
  111 72 F 4 69.8 25.8 44 65 0.6
  121 60 M 5 153 49.96 42 62 1.48
  128 62 F 12 86 31.59 68 82 1.67
  135 48 M 20 101.6 33.79 79 60 1.3
  1. HbA1c - Glycated haemoglobin; LVEF – left ventricular ejection fraction.